Savant Capital LLC Sells 2,520 Shares of Lincoln National Co. (NYSE:LNC)

Savant Capital LLC decreased its stake in shares of Lincoln National Co. (NYSE:LNC) by 7.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 30,123 shares of the financial services provider’s stock after selling 2,520 shares during the period. Savant Capital LLC’s holdings in Lincoln National were worth $955,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Blue Trust Inc. grew its holdings in shares of Lincoln National by 535.5% during the 3rd quarter. Blue Trust Inc. now owns 1,074 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 905 shares during the period. Larson Financial Group LLC raised its holdings in Lincoln National by 95.3% in the third quarter. Larson Financial Group LLC now owns 1,086 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 530 shares in the last quarter. Eastern Bank purchased a new position in Lincoln National during the third quarter valued at $40,000. Meeder Asset Management Inc. purchased a new position in Lincoln National during the third quarter valued at $48,000. Finally, Crews Bank & Trust bought a new stake in shares of Lincoln National during the 4th quarter valued at $51,000. Hedge funds and other institutional investors own 72.81% of the company’s stock.

Lincoln National Stock Performance

Shares of LNC stock opened at $39.09 on Friday. The company has a quick ratio of 0.27, a current ratio of 0.27 and a debt-to-equity ratio of 0.80. The company has a 50 day moving average price of $33.32 and a 200-day moving average price of $32.70. Lincoln National Co. has a 52 week low of $25.60 and a 52 week high of $39.85. The firm has a market capitalization of $6.66 billion, a PE ratio of 2.13, a P/E/G ratio of 0.28 and a beta of 1.79.

Lincoln National (NYSE:LNC) last announced its earnings results on Thursday, February 6th. The financial services provider reported $1.91 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.04. Lincoln National had a net margin of 17.76% and a return on equity of 18.47%. As a group, equities research analysts expect that Lincoln National Co. will post 7.63 earnings per share for the current year.

Analyst Ratings Changes

LNC has been the subject of a number of recent research reports. Wells Fargo & Company lowered their price target on shares of Lincoln National from $29.00 to $28.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 14th. Keefe, Bruyette & Woods lifted their target price on shares of Lincoln National from $37.00 to $40.00 and gave the company a “market perform” rating in a report on Wednesday. TD Cowen upped their price target on Lincoln National from $34.00 to $37.00 and gave the stock a “hold” rating in a research note on Wednesday, November 27th. Barclays lifted their price objective on Lincoln National from $36.00 to $38.00 and gave the company an “equal weight” rating in a research note on Friday, February 7th. Finally, StockNews.com raised Lincoln National from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $35.40.

Lincoln National Company Profile

Lincoln National Corporation, through its subsidiaries, operates multiple insurance and retirement businesses in the United States. It operates in four segments: Life Insurance, Annuities, Group Protection, and Retirement Plan Services. The Life Insurance segment provides life insurance products, including term insurance, universal life insurance (UL), indexed universal life insurance, variable universal life insurance (VUL), linked-benefit UL and VUL products, and critical illness and long-term care riders.